Intel Corporation (INTC) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$0.22	$0.42	+90.9%	—	—	—
Q4 26	$0.01	$0.29	+2800.0%	—	—	—
Q3 26	$0.08	$0.15	+87.5%	—	—	—
Q2 26	$0.01	$0.23	+2200.0%	—	—	—
Q1 26	$0.01	-$0.1	-1100.0%	—	—	—
Q4 25	—	$0.13	—	—	—	—
Q3 25	$0.12	$0.13	+8.3%	—	—	—
Q2 25	-$0.03	-$0.46	-1433.3%	—	—	—
Q1 25	$0.1	$0.02	-80.0%	—	—	—
Q4 24	$0.14	$0.18	+28.6%	—	—	—
Q3 24	$0.45	$0.54	+20.0%	—	—	—
Q2 24	$0.22	$0.41	+86.4%	—	—	—
Q1 24	-$0.03	$0.13	+533.3%	—	—	—
Q4 23	-$0.15	-$0.04	+73.3%	—	—	—
Q3 23	$0.2	$0.1	-50.0%	—	—	—
Q2 23	$0.32	$0.59	+84.4%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$0.06	—	—	$52.9B	—
FY24	—	-$4.38	—	—	$53.1B	—
FY23	—	$0.4	—	—	$54.2B	—
FY22	—	$1.95	—	—	$63.1B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$59.4B	$62.8B	$70.8B	$72B	$77.9B	$79B	$63.1B	$54.2B	$53.1B	$52.9B
YoY change	+7.28%	+5.68%	+12.9%	+1.58%	+8.2%	+1.49%	-20.2%	-14%	-2.08%	-0.47%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	59.4B	62.8B	70.8B	72B	77.9B	79B	63.1B	54.2B	53.1B	52.9B
Cost of revenue	23.2B	23.7B	27.1B	29.8B	34.3B	35.2B	36.2B	32.5B	35.8B	34.5B
Gross profit	36.2B	39.1B	43.7B	42.1B	43.6B	43.8B	26.9B	21.7B	17.3B	18.4B
Gross margin	61%	62.3%	61.7%	58.6%	56%	55.4%	42.6%	40%	32.7%	34.8%
Research & development	12.7B	13B	13.5B	13.4B	13.6B	15.2B	17.5B	16B	16.5B	13.8B
Selling, general & administrative	8.4B	7.5B	7B	6.3B	6.2B	6.5B	7B	5.6B	5.5B	4.6B
Operating expenses	21.1B	20.5B	20.5B	19.7B	19.7B	21.7B	24.5B	21.7B	22.1B	18.4B
Operating income	14.9B	18.4B	23.2B	22.4B	23.9B	22.1B	2.3B	31M	-4.7B	-23M
Operating margin	25.1%	29.4%	32.8%	31.2%	30.7%	27.9%	3.7%	0.06%	-8.87%	-0.04%
Non-operating income, net	-1.2B	2.3B	-53M	1.1B	1.7B	103M	5.3B	102M	-7.5B	1.9B
Pretax income	12.9B	20.4B	23.3B	24.1B	25.1B	21.7B	7.8B	762M	-11.2B	1.6B
Income tax	2.6B	10.8B	2.3B	3B	4.2B	1.8B	-249M	-913M	8B	1.5B
Net income	10.3B	9.6B	21.1B	21B	20.9B	19.9B	8B	1.7B	-19.2B	26M
Net margin	17.4%	15.3%	29.7%	29.2%	26.8%	25.1%	12.7%	3.09%	-36.2%	0.05%
EBITDA	22.7B	26.9B	32.9B	34.2B	36.2B	34B	16B	11.1B	8.7B	12.5B
EPS	2.18	2.04	4.57	4.77	4.98	4.89	1.95	0.4	-4.38	-0.06
Diluted EPS	2.12	1.99	4.48	4.71	4.94	4.86	1.94	0.4	-4.38	-0.06

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	14.2B	15.4B	12.7B	12.8B	13.3B	14.3B	12.7B	12.9B	13.7B	13.7B	13.6B	16.1B
Cost of revenue	8.1B	8.4B	7.5B	8.3B	11.3B	8.7B	8B	9.3B	8.4B	8.7B	8.2B	9.6B
Gross profit	6B	7B	5.2B	4.5B	2B	5.6B	4.7B	3.5B	5.2B	4.9B	5.3B	6.5B
Gross margin	42.5%	45.7%	41%	35.4%	15%	39.2%	36.9%	27.5%	38.2%	36.1%	39.4%	40.4%
Research & development	3.9B	4B	4.4B	4.2B	4B	3.9B	3.6B	3.7B	3.2B	3.2B	3.4B	3.4B
Selling, general & administrative	1.3B	1.6B	1.6B	1.3B	1.4B	1.2B	1.2B	1.1B	1.1B	1.2B	1B	1.2B
Operating expenses	5.2B	5.6B	5.9B	5.6B	5.4B	5.1B	4.8B	4.8B	4.4B	4.4B	4.4B	4.5B
Operating income	808M	1.4B	-721M	-1B	-3.4B	469M	-145M	-1.3B	858M	550M	934M	2B
Operating margin	5.71%	9.37%	-5.67%	-7.96%	-25.9%	3.29%	-1.14%	-10%	6.28%	4.02%	6.88%	12.2%
Non-operating income, net	-1B	1.2B	-143M	-1.1B	-5.8B	-496M	-268M	-1.3B	3.9B	-398M	-5.2B	-12.7B
Pretax income	-52M	2.8B	-719M	-2B	-9.1B	599M	-586M	-2.8B	4.6B	338M	-3.9B	-10.8B
Income tax	-362M	128M	-282M	-350M	7.9B	752M	301M	255M	304M	671M	335M	29M
Net income	310M	2.7B	-437M	-1.7B	-17B	-153M	-887M	-3B	4.3B	-333M	-4.3B	-10.8B
Net margin	2.19%	17.3%	-3.43%	-12.9%	-127.9%	-1.07%	-7%	-23.5%	31.3%	-2.44%	-31.5%	-67.3%
EBITDA	3.6B	4.3B	2.2B	1.9B	555M	4B	2.7B	1.8B	3.9B	4B	4.7B	5.5B
EPS	0.07	0.63	-0.09	-0.38	-3.88	-0.03	-0.19	-0.67	0.9	-0.12	-0.73	-2.16
Diluted EPS	0.07	0.63	-0.09	-0.38	-3.88	-0.03	-0.19	-0.67	0.9	-0.12	-0.73	-2.16

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	171.6B	217B	216.4B	264.4B	209.2B	209B	108.6B	210.5B	85.8B	167.2B	613.3B
Enterprise value	179.7B	229.8B	231.1B	280.2B	221.7B	217.9B	122.2B	234.8B	113.8B	176.3B	656.8B
Shares outstanding	4.7B	4.7B	4.6B	4.4B	4.2B	4.1B	4.1B	4.2B	4.3B	4.5B	4.5B

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	16.6	22.6	10.3	12.6	10	10.5	13.5	125.7	—	6.4K	809.3
P/S	2.89	3.46	3.05	3.67	2.69	2.65	1.72	3.88	1.62	3.16	11.4
P/B	2.59	3.14	2.9	3.41	2.58	2.19	1.05	1.91	0.82	1.32	7.09
EV/EBITDA	7.92	8.56	7.02	8.19	6.12	6.41	7.62	21.1	13.1	14.1	39
EV/Sales	3.03	3.66	3.26	3.89	2.85	2.76	1.94	4.33	2.14	3.34	11.5
Earnings yield	6.01%	4.42%	9.73%	7.96%	9.99%	9.5%	7.38%	0.8%	—	0.02%	0.12%
FCF yield	7.1%	4.76%	6.59%	6.4%	10.2%	4.37%	-8.86%	-6.78%	-18.2%	-2.96%	0.79%
PEG	—	—	—	—	—	—	—	—	—	—	3.64

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	61%	62.3%	61.7%	58.6%	56%	55.4%	42.6%	40%	32.7%	34.8%	40.4%
Operating margin	25.1%	29.4%	32.8%	31.2%	30.7%	27.9%	3.7%	0.06%	-8.87%	-0.04%	12.2%
Net margin	17.4%	15.3%	29.7%	29.2%	26.8%	25.1%	12.7%	3.09%	-36.2%	0.05%	-19.8%
ROE	15.6%	13.9%	28.2%	27.2%	25.8%	20.8%	7.76%	1.52%	-18.3%	0.02%	-10.7%
ROA	9.1%	7.79%	16.5%	15.4%	13.7%	11.8%	4.4%	0.87%	-9.79%	0.01%	1.41%
ROIC	15.9%	10.6%	23.5%	21%	21.3%	19.4%	2%	0.02%	-3.54%	-0%	3.48%
Return on tangible assets	15.6%	19.6%	38.1%	33.8%	25.8%	19.9%	6.98%	1.32%	-13.8%	0.02%	-7.16%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.75	1.69	1.73	1.4	1.91	2.13	1.57	1.54	1.33	2.02	1.6
Quick ratio	1.48	1.29	1.3	1.01	1.57	1.74	1.16	1.15	0.98	1.65	1.25
Debt / equity	0.38	0.39	0.35	0.37	0.45	0.4	0.41	0.45	0.48	0.37	0.49
Debt / assets	0.22	0.22	0.21	0.21	0.24	0.23	0.23	0.26	0.25	0.22	0.25
Net debt / EBITDA	0.36	0.48	0.45	0.46	0.35	0.26	0.85	2.18	3.22	0.73	1.15
Interest coverage	18.6	32.5	50.8	50.2	40.9	37.4	16.7	1.87	-9.84	2.43	-7.57
Effective tax rate	20.3%	52.8%	9.71%	12.5%	16.7%	8.46%	0%	0%	0%	98.3%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	12.6	13.4	15.4	16.3	18.5	19.5	15.3	12.9	12.4	11.7	11.6
EPS (basic)	2.18	2.04	4.57	4.77	4.98	4.89	1.95	0.4	-4.38	-0.06	-0.06
EPS (diluted)	2.12	1.99	4.48	4.71	4.94	4.86	1.94	0.4	-4.38	-0.06	-2.09
Book value per share	14	14.7	16.2	17.5	19.3	23.5	25.1	26.2	24.5	27.9	17.4
FCF per share	2.58	2.2	3.09	3.83	5.1	2.25	-2.34	-3.41	-3.66	-1.09	0.55
Cash per share	3.62	2.98	2.53	2.97	5.69	7.21	6.9	5.97	5.15	8.26	5.89
Capex per share	2.03	2.51	3.29	3.67	3.44	5.01	6.1	6.15	5.59	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	16.2%	18.8%	21.4%	22.5%	18.6%	25.7%	39.7%	47.5%	45.1%	—	—
Capex / operating cash flow	40.4%	44.1%	53.7%	47.3%	38.7%	66.9%	112.4%	212.3%	368.4%	—	—
Payout ratio	47.7%	52.8%	26.3%	26.5%	26.6%	28.4%	74.8%	184.4%	-8.31%	0%	0%
Dividend yield	2.87%	2.34%	2.56%	2.11%	2.66%	2.7%	5.52%	1.47%	1.86%	0%	0.43%

Yield

0.43%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.125

ex-dividend Aug 7, 2024

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 7, 2024	$0.125
May 6, 2024	$0.125
Feb 6, 2024	$0.125

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$14.2B	$15.4B	$12.7B	$12.8B	$13.3B	$14.3B	$12.7B	$12.9B	$13.7B	$13.7B	$13.6B	$16.1B
YoY change	-7.69%	+9.71%	+8.61%	-0.9%	-6.17%	-7.44%	-0.45%	+0.2%	+2.78%	-4.11%	+7.18%	+25.4%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	17.1B	14B	11.7B	13.1B	23.9B	29.3B	28.3B	25B	22.1B	37.4B
Receivables	4.7B	5.6B	6.7B	7.7B	6.8B	9.5B	4.1B	3.4B	3.5B	3.8B
Inventory	5.6B	7B	7.3B	8.7B	8.4B	10.8B	13.2B	11.1B	12.2B	11.6B
Total current assets	35.5B	29.5B	28.8B	31.2B	47.2B	58.6B	50.4B	43.3B	47.3B	63.7B
Property, plant & equipment	63.1B	69.2B	81.4B	94.8B	56.6B	63.2B	80.9B	96.6B	107.9B	105.4B
Goodwill & intangibles	47.2B	74.3B	72.7B	74.2B	72B	68.5B	67.2B	64.4B	56.8B	53.4B
Total assets	113.3B	123.2B	128B	136.5B	153.1B	168.4B	182.1B	191.6B	196.5B	211.4B
Accounts payable	2.5B	2.9B	3.8B	4.1B	5.6B	5.7B	9.6B	8.6B	12.6B	9.9B
Short-term debt	4.6B	1.8B	1.3B	3.7B	2.5B	4.6B	4.3B	2.3B	3.7B	2.5B
Total current liabilities	20.3B	17.4B	16.6B	22.3B	24.8B	27.5B	32.2B	28.1B	35.7B	31.6B
Long-term debt	20.6B	25B	25.1B	25.3B	33.9B	33.5B	37.7B	47B	46.3B	44.1B
Total liabilities	47.1B	54.2B	53.4B	59B	72.1B	73B	78.8B	81.6B	91.5B	85.1B
Shareholders' equity	66.2B	69B	74.6B	77.5B	81B	95.4B	103.3B	110B	105B	126.4B
Total debt	25.3B	26.8B	26.4B	29B	36.4B	38.1B	42B	49.3B	50B	46.6B
Net debt	19.7B	23.4B	23.3B	24.8B	30.5B	33.3B	30.9B	42.2B	41.8B	32.3B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	25B	—	—	—	—	—	—	—	30.9B	37.4B	32.8B	29.7B
Receivables	2.8B	—	—	—	—	—	—	—	3.2B	3.8B	4.1B	4B
Inventory	11.5B	—	—	—	—	—	—	—	11.5B	11.6B	12.4B	12.5B
Total current assets	43.8B	—	—	—	—	—	—	—	51.7B	63.7B	62.2B	57.2B
Property, plant & equipment	-97.1B	—	—	—	—	—	—	—	-105.1B	105.4B	-107.9B	-109.9B
Goodwill & intangibles	65.1B	4.6B	4.7B	4.4B	4B	3.7B	3.6B	3.1B	53.6B	53.4B	46.4B	46B
Total assets	188.8B	—	—	—	—	—	—	—	204.5B	211.4B	205.3B	202.4B
Accounts payable	8.7B	—	—	—	—	—	—	—	10.3B	9.9B	7.2B	8.8B
Short-term debt	2.3B	—	—	—	—	—	—	—	2.5B	2.5B	2B	2B
Total current liabilities	28.6B	—	—	—	—	—	—	—	32.3B	31.6B	26.9B	35.7B
Long-term debt	46.6B	—	—	—	—	—	—	—	44.1B	44.1B	43B	48.5B
Total liabilities	83.2B	—	—	—	—	—	—	—	87.8B	85.1B	80.3B	99.3B
Shareholders' equity	105.7B	—	—	—	—	—	—	—	116.7B	126.4B	125B	103.1B
Total debt	48.9B	—	—	—	—	—	—	—	46.6B	46.6B	45B	50.5B
Net debt	41.3B	—	—	—	—	—	—	—	35.4B	32.3B	27.8B	37.7B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	10.3B	9.6B	21.1B	21B	20.9B	19.9B	8B	1.7B	-19.2B	26M
Depreciation & amortization	7.8B	8.1B	9.1B	10.8B	12.2B	11.8B	13B	9.6B	11.4B	11.7B
Stock-based compensation	1.4B	1.4B	1.5B	1.7B	1.9B	2B	3.1B	3.2B	3.4B	2.4B
Change in working capital	2.1B	5.7B	-1.6B	325M	2.1B	-5.9B	-3B	-2B	1.3B	-2.5B
Operating cash flow	23.8B	26.7B	28.3B	34.3B	37.3B	30.4B	22.3B	12.1B	6.5B	9.7B
Capital expenditure	-9.6B	-11.8B	-15.2B	-16.2B	-14.5B	-20.3B	-25.1B	-25.8B	-23.9B	—
Investing cash flow	-25.8B	-15.8B	-11.2B	-14.4B	-21.5B	-24.3B	-10.2B	-24B	-18.3B	-175M
Dividends paid	-4.9B	-5.1B	-5.5B	-5.6B	-5.6B	-5.6B	-6B	-3.1B	-1.6B	0
Share repurchases	-2.6B	-3.6B	-10.7B	-13.6B	-14.2B	-2.4B	0	0	—	—
Financing cash flow	-6.8B	-9.2B	-18.7B	-18.3B	-13.6B	-7.2B	1.2B	3.5B	15.5B	-5.4B
Net change in cash	-8.8B	1.7B	-1.7B	1.6B	2.2B	-1.1B	13.2B	-8.4B	3.8B	4.1B
Free cash flow	12.2B	10.3B	14.3B	16.9B	21.4B	9.1B	-9.6B	-14.3B	-15.7B	-4.9B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	310M	2.7B	-437M	-1.7B	-17B	-153M	-887M	-3B	4.3B	-333M	-4.3B	-10.8B
Depreciation & amortization	2.4B	2.5B	2.6B	2.6B	3.6B	2.6B	2.7B	3B	3B	3B	3.1B	3.2B
Stock-based compensation	772M	796M	1.2B	780M	800M	651M	684M	664M	548M	538M	621M	686M
Change in working capital	2.9B	-671M	-3.4B	-1B	795M	2.4B	-1B	-815M	-884M	212M	-2.3B	424M
Operating cash flow	6.9B	4.2B	274M	1.6B	-8.4B	5.4B	1.4B	-75M	2.5B	4.3B	1.1B	7B
Capital expenditure	-5.8B	-6.7B	-6B	-5.7B	-6.5B	-5.8B	-5.2B	-3.5B	—	—	—	—
Investing cash flow	-7.3B	-5.3B	-2.6B	-9.2B	-2.8B	-3.7B	81M	-2.1B	-3.8B	-3.1B	6.7B	-1.2B
Dividends paid	-525M	-527M	-529M	-534M	-536M	0	0	0	0	0	—	—
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	470M	-890M	3B	8.6B	-8.9B	62M	-687M	-714M	-4.8B	831M	-1.6B	-20.3B
Net change in cash	123M	-2.1B	715M	1.1B	-20B	1.7B	836M	-2.9B	-6.1B	2B	6.2B	-14.5B
Free cash flow	71M	-2.1B	-7.2B	-3.4B	-2.4B	-2.7B	-4.4B	-1.5B	121M	800M	-2.5B	4.5B

Date	Ratio
Jul 31, 2000	2:1
Apr 12, 1999	2:1
Jul 14, 1997	2:1
Jun 19, 1995	2:1
Jun 7, 1993	2:1
Oct 29, 1987	3:2
Jul 1, 1983	2:1
Oct 9, 1980	2:1

Intel Corporation Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history